COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.981
-0.019 (-0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed

COSCIENS Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
4.834.55.645.263.650.53
Upgrade
Revenue Growth (YoY)
-25.23%-20.25%7.22%44.03%586.47%-98.02%
Upgrade
Cost of Revenue
0.670.220.160.092.320.41
Upgrade
Gross Profit
4.174.285.485.171.340.12
Upgrade
Selling, General & Admin
12.598.728.237.275.897.83
Upgrade
Research & Development
17.413.5612.516.571.511.84
Upgrade
Other Operating Expenses
--0.12--0.140.17
Upgrade
Operating Expenses
29.9922.2820.8613.847.269.84
Upgrade
Operating Income
-25.83-18.01-15.38-8.67-5.93-9.71
Upgrade
Interest Expense
-0.01-0.01-0-0.01-0-0.59
Upgrade
Interest & Investment Income
1.131.13----
Upgrade
Currency Exchange Gain (Loss)
-0.22-0.210.880.220.570.09
Upgrade
Other Non Operating Income (Expenses)
2.16-0-0.010.424.52
Upgrade
EBT Excluding Unusual Items
-22.77-17.1-14.5-8.48-4.94-5.7
Upgrade
Merger & Restructuring Charges
------0.51
Upgrade
Impairment of Goodwill
---7.64---
Upgrade
Gain (Loss) on Sale of Assets
0.550.55----
Upgrade
Asset Writedown
-1.46--0.58---0.02
Upgrade
Other Unusual Items
----0.22-
Upgrade
Pretax Income
-23.68-16.55-22.73-8.48-4.72-6.23
Upgrade
Income Tax Expense
-0.47---0.110.4-0.19
Upgrade
Earnings From Continuing Operations
-23.21-16.55-22.73-8.37-5.12-6.04
Upgrade
Net Income
-23.21-16.55-22.73-8.37-5.12-6.04
Upgrade
Net Income to Common
-23.21-16.55-22.73-8.37-5.12-6.04
Upgrade
Shares Outstanding (Basic)
211100
Upgrade
Shares Outstanding (Diluted)
211100
Upgrade
Shares Change (YoY)
6.18%-5.63%179.74%134.83%2.70%
Upgrade
EPS (Basic)
-14.28-13.63-18.72-7.28-12.46-34.54
Upgrade
EPS (Diluted)
-14.28-13.63-18.72-7.28-12.46-35.00
Upgrade
Free Cash Flow
-27.93-17.14-13.69-8.61-4.13-10.73
Upgrade
Free Cash Flow Per Share
-17.19-14.12-11.28-7.49-10.05-61.30
Upgrade
Gross Margin
86.18%95.06%97.22%98.29%36.56%22.93%
Upgrade
Operating Margin
-534.30%-400.36%-272.64%-164.85%-162.24%-1825.75%
Upgrade
Profit Margin
-480.12%-367.99%-402.96%-159.09%-140.14%-1135.71%
Upgrade
Free Cash Flow Margin
-577.70%-380.99%-242.75%-163.71%-113.06%-2015.98%
Upgrade
EBITDA
-25.68-17.99-15.36-8.53-5.69-9.4
Upgrade
EBITDA Margin
---272.36%-162.09%-155.89%-
Upgrade
D&A For EBITDA
0.150.020.020.150.230.32
Upgrade
EBIT
-25.83-18.01-15.38-8.67-5.93-9.71
Upgrade
EBIT Margin
---272.64%-164.85%-162.24%-
Upgrade
Revenue as Reported
-----0.53
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.